![Justin Chen Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Justin Chen Li
Sociétés | Poste | Début | Fin |
---|---|---|---|
Helio Genomics, Inc.
![]() Helio Genomics, Inc. Information Technology ServicesTechnology Services Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - |
Historique de carrière de Justin Chen Li
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Helio Genomics, Inc.
![]() Helio Genomics, Inc. Information Technology ServicesTechnology Services Helio Genomics, Inc. is a leading healthcare company based in Irvine, CA, that focuses on early cancer detection through cutting-edge research and development. The private company's mission is to simplify cancer screening and enhance patient outcomes across diverse populations. Helio Genomics has pioneered breakthrough innovations in genomics, providing a strong foundation for its sister company, Lamh. Helio Genomics is an AI-driven healthcare company that commercializes early cancer detection tests from a simple blood draw. The company's development program is focused on liver, colon, breast, and lung cancer. The company has R&D, GMP, and CLIA facilities in Irvine, CA, and West Lafayette, IN. The CEO of the company is Justin Chen Li. | Technology Services |
- Bourse
- Insiders
- Justin Chen Li
- Expérience